These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 16837108)

  • 1. Haplotypes in cathechol-O-methyltransferase gene confer increased risk for psychosis in Alzheimer disease.
    Borroni B; Grassi M; Costanzi C; Zanetti M; Archetti S; Franzoni S; Caimi L; Padovani A
    Neurobiol Aging; 2007 Aug; 28(8):1231-8. PubMed ID: 16837108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.
    Sweet RA; Devlin B; Pollock BG; Sukonick DL; Kastango KB; Bacanu SA; Chowdari KV; DeKosky ST; Ferrell RE
    Mol Psychiatry; 2005 Nov; 10(11):1026-36. PubMed ID: 16027741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catechol-O-methyltransferase gene polymorphism is associated with risk of psychosis in Alzheimer Disease.
    Borroni B; Agosti C; Archetti S; Costanzi C; Bonomi S; Ghianda D; Lenzi GL; Caimi L; Di Luca M; Padovani A
    Neurosci Lett; 2004 Nov; 370(2-3):127-9. PubMed ID: 15488308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BDNF genetic variations increase the risk of Alzheimer's disease-related depression.
    Borroni B; Grassi M; Archetti S; Costanzi C; Bianchi M; Caimi L; Caltagirone C; Di Luca M; Padovani A
    J Alzheimers Dis; 2009; 18(4):867-75. PubMed ID: 19661618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
    Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M
    Pharmacogenet Genomics; 2008 Sep; 18(9):815-21. PubMed ID: 18698234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families.
    Chen X; Wang X; O'Neill AF; Walsh D; Kendler KS
    Mol Psychiatry; 2004 Oct; 9(10):962-7. PubMed ID: 15124004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
    Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
    Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
    Molero P; Ortuño F; Zalacain M; Patiño-García A
    Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol-O-methyltransferase genotype is associated with plasma total homocysteine levels and may increase venous thrombosis risk.
    Gellekink H; Muntjewerff JW; Vermeulen SH; Hermus AR; Blom HJ; den Heijer M
    Thromb Haemost; 2007 Dec; 98(6):1226-31. PubMed ID: 18064318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-gene interaction between MAOA and COMT in suicidal behavior.
    De Luca V; Tharmalingam S; Sicard T; Kennedy JL
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):151-4. PubMed ID: 15936529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An association study between cathechol-O-methyltransferase gene and mental retardation in the Chinese Han population.
    Zhang K; Gao J; An C; Gao X; Zheng Z; Li R; Huang S; Zhang F
    Neurosci Lett; 2007 May; 419(1):83-7. PubMed ID: 17442488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COMT haplotypes suggest P2 promoter region relevance for schizophrenia.
    Palmatier MA; Pakstis AJ; Speed W; Paschou P; Goldman D; Odunsi A; Okonofua F; Kajuna S; Karoma N; Kungulilo S; Grigorenko E; Zhukova OV; Bonne-Tamir B; Lu RB; Parnas J; Kidd JR; DeMille MM; Kidd KK
    Mol Psychiatry; 2004 Sep; 9(9):859-70. PubMed ID: 15098000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haplotypes of catechol-O-methyltransferase modulate intelligence-related brain white matter integrity.
    Liu B; Li J; Yu C; Li Y; Liu Y; Song M; Fan M; Li K; Jiang T
    Neuroimage; 2010 Mar; 50(1):243-9. PubMed ID: 20005296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women.
    Sazci A; Ergul E; Kucukali I; Kilic G; Kaya G; Kara I
    Brain Res Mol Brain Res; 2004 Dec; 132(1):51-6. PubMed ID: 15548428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia.
    Zinkstok J; Schmitz N; van Amelsvoort T; Moeton M; Baas F; Linszen D
    Genes Brain Behav; 2008 Feb; 7(1):61-9. PubMed ID: 17504246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures.
    Kamboh MI; Minster RL; Feingold E; DeKosky ST
    Mol Psychiatry; 2006 Mar; 11(3):273-9. PubMed ID: 16302009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in alpha(1)-antichymotrypsin and its association with Alzheimer's disease.
    Wang X; DeKosky ST; Luedecking-Zimmer E; Ganguli M; Kamboh MI
    Hum Genet; 2002 Apr; 110(4):356-65. PubMed ID: 11941486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms.
    Borroni B; Grassi M; Agosti C; Costanzi C; Archetti S; Franzoni S; Caltagirone C; Di Luca M; Caimi L; Padovani A
    Neurobiol Aging; 2006 Nov; 27(11):1595-603. PubMed ID: 16257094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COMT polymorphisms and anxiety-related personality traits.
    Stein MB; Fallin MD; Schork NJ; Gelernter J
    Neuropsychopharmacology; 2005 Nov; 30(11):2092-102. PubMed ID: 15956988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.